首页|自拟参芪消癌方联合替吉奥维持治疗老年晚期胃癌患者的疗效观察

自拟参芪消癌方联合替吉奥维持治疗老年晚期胃癌患者的疗效观察

扫码查看
目的 探讨自拟参芪消癌方联合替吉奥维持治疗老年晚期胃癌(Gastric cancer)的临床疗效.方法 选取2021年6月-2022年6月期间河南省南阳市第二人民医院收治的晚期胃癌患者90例,采用随机数字表法分为对照组和观察组,每组各45例.两组患者均采用SOX方案进行化疗,化疗结束后4周,对照组给予替吉奥胶囊口服,观察组在对照组基础上给予参芪消癌方口服.观察比较两组患者临床疗效、毒副反应,治疗前后中医证候积分、KPS 评分及肿瘤标志物[癌胚抗原(Carcinoembryonic antigen,CEA)、糖类抗原 199(Glycoantigen 199,CA199)、糖类抗原724(Glycoantigen 724,CA724)]水平.结果 治疗后两组患者中医证候积分较治疗前明显降低,KPS评分较治疗前升高,差异有统计学意义(P<0.05);观察组中医证候积分明显低于对照组,KPS评分明显高于对照组,差异有统计学意义(P<0.05).治疗后两组患者CEA、CA199、CA724水平均较治疗前明显降低,差异有统计学意义(P<0.05);且观察组肿瘤标志物水平明显低于对照组,差异有统计学意义(P<0.05).治疗后观察组临床控制率75.56%(34/45)明显高于对照组48.89%(22/45),差异有统计学意义(P<0.05).治疗期间,观察组在恶心呕吐、腹泻、血小板减少等毒副反应程度均好于对照组,差异有统计学意义(P<0.05).结论 自拟参芪消癌方联合替吉奥维持能有效改善晚期胃癌患者临床症状及生活质量,延缓瘤体进展,有助于降低晚期胃癌患者肿瘤标志物水平,增强抗肿瘤效果,同时还能减轻因化疗而产生的毒副作用,安全性较高,耐受性较好.
Observation of the Efficacy of Self-Made Shenqi Xiaoai Formula Combined with Tegio for Maintenance Therapy in Elderly Patients with Advanced Gastric Cancer
Objective To explore the clinical efficacy of self-made Shenqi Xiaoai formula combined with Tegio for maintenance therapy in elderly patients with advanced gastric cancer.Methods From June 2021 to June 2022,90 pa-tients with advanced gastric cancer admitted to Nanyang Second General Hospital,were selected as the study subjects.They were divided into a control group and an observation group according to the random number table method,with 45 patients in each group.Both groups underwent chemotherapy using the SOX regimen.Four weeks after the end of chemotherapy,the control group received oral Tegio capsules,while the observation group received oral Shenqi Xiaoai formula in addition to the Tegio capsules.Clinical efficacy,side effects,traditional Chinese medicine(TCM)syndrome scores,Karnofsky Perform-ance Status(KPS)scores,and tumor markers[carcinoembryonic antigen(CEA),glycoantigen 199(CA1 99),glycoantigen 724(CA72-4)]levels were observed and compared between the two groups before and after treatment.Results After treatment,TCM syndrome scores significantly decreased,and KPS scores significantly increased in both groups compared to before treatment,with a statistically significant difference(P<0.05).The observation group had significantly lower TCM syndrome scores and higher KPS scores than the control group,with a statistically significant difference(P<0.05).CEA,CA199,and CA724 levels significantly decreased in both groups compared to before treatment,with a statistically signifi-cant difference(P<0.05);the observation group showed significantly lower levels of these tumor markers than the control group,with a statistically significant difference(P<0.05).The clinical control rate in the observation group was 75.56%(34/45),significantly higher than the control group's 48.89%(22/45),with a statistically significant difference(P<0.05).During the treatment,the severity of side effects such as nausea,vomiting,diarrhea,and thrombocytopenia was sig-nificantly lower in the observation group compared to the control group,with a statistically significant difference(P<0.05).Conclusion The combination of self-made Shenqi Xiaoai formula and Tegio for maintenance therapy can effec-tively improve the clinical symptoms and quality of life in elderly patients with advanced gastric cancer,slow tumor progres-sion,reduce tumor markers levels,enhance anti-tumor efficacy,and alleviate chemotherapy-induced side effects,demon-strating high safety and good tolerance.

Self-made Shenqi Xiaoai FormulaTegioAdvanced Gastric Cancer

王苗、候楠、高新雅

展开 >

河南省南阳市第二人民医院胃肠肿瘤科,河南南阳 473000

自拟参芪消癌方 替吉奥 晚期胃癌

河南省医学科技攻关计划项目

LHGJ20210974

2024

世界中西医结合杂志
中华中医药学会

世界中西医结合杂志

CSTPCD
影响因子:1.053
ISSN:1673-6613
年,卷(期):2024.19(7)
  • 17